BioVie Inc. Other Current Liabilities
BioVie Inc. (BIVI) had Other Current Liabilities of $48.38 thousand as of 2023-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2024-09-30
- 2023-06-30: Other Liabilities, Current $48.38K.
- 2023-03-31: Other Liabilities, Current $193.54K.
- 2022-12-31: Other Liabilities, Current $338.70K.
- 2022-09-30: Other Liabilities, Current $483.85K.
| Period end | Other Liabilities, Current |
|---|---|
| 2023-06-30 | $48.38K 10-K · filed 2024-09-30 |
| 2023-03-31 | $193.54K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $338.70K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $483.85K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.30M 10-K · filed 2023-08-16 |
| 2022-03-31 | $580.63K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $580.63K 10-Q · filed 2022-02-08 |
| 2021-09-30 | $580.63K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |